Jeffrey B. Matthews

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau et al. · JAMA Oncology · 2020 · 706 citations · Full text

Medicine, Oncology, Pharmacology +16

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf et al. · Cancer Cell · 2021 · 330 citations · Full text

Medicine, Oncology, Pharmacology +10

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Denise M. Wolf, Christina Yau, Julia Wulfkuhle et al. · Cancer Cell · 2022 · 326 citations · Full text

Medicine, Cancer Biology, Oncology +17

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

Douglas Yee, Angela DeMichele, Christina Yau et al. · JAMA Oncology · 2020 · 225 citations · Full text

Medicine, Oncology, Breast Oncology +15

Geriatric Assessment Improves Prediction of Surgical Outcomes in Older Adults Undergoing Pancreaticoduodenectomy

William Dale, Joshua Hemmerich, Alaine Kamm et al. · Annals of Surgery · 2013 · 158 citations · Full text

Medicine, Geriatric Medicine, Surgery +17